StockData
Ocugen, Inc. logo

Ocugen, Inc. (OCGN) income statement

OCGNNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 1/30
$0.77+0.04 (+4.79%)

Close on Nov 20, 2026Market cap $260.40MP/E –Yield –

See a number that looks wrong?